- Home
- ITHA vs SRZN Comparison
ITHA vs SRZN Comparison
Compare ITHA & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$29.51
Company Overview
Basic Information| Metric | ITHA | SRZN |
|---|---|---|
| Founded | 2025 | 2015 |
| Country | United States | United States |
| Employees | N/A | 59 |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 308.5M | 271.6M |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ITHA | SRZN |
|---|---|---|
| Price | $10.06 | $29.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | 38.0K | ★ 649.0K |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,477,000.00 |
| Revenue This Year | N/A | $75.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.86 | $11.39 |
| 52 Week High | $10.11 | $37.83 |
Technical Indicators
Market Signals| Indicator | ITHA | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 54.23 | 66.26 |
| Support Level | $9.89 | $24.64 |
| Resistance Level | $10.09 | $33.96 |
| Average True Range (ATR) | 0.01 | 2.24 |
| MACD | -0.00 | 1.46 |
| Stochastic Oscillator | 28.57 | 61.60 |
Price Performance
Historical Comparison ITHA
SRZN
About ITHA ITHAX Acquisition Corp III Class A Ordinary Shares
ITHAX Acquisition Corp III is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).